173 related articles for article (PubMed ID: 17719258)
1. Listeria as a vaccine vector.
Bruhn KW; Craft N; Miller JF
Microbes Infect; 2007 Aug; 9(10):1226-35. PubMed ID: 17719258
[TBL] [Abstract][Full Text] [Related]
2. Recent advances with recombinant bacterial vaccine vectors.
Shata MT; Stevceva L; Agwale S; Lewis GK; Hone DM
Mol Med Today; 2000 Feb; 6(2):66-71. PubMed ID: 10652479
[TBL] [Abstract][Full Text] [Related]
3. Promises and challenges for the development of Listeria monocytogenes-based immunotherapies.
Brockstedt DG; Dubensky TW
Expert Rev Vaccines; 2008 Sep; 7(7):1069-84. PubMed ID: 18767955
[TBL] [Abstract][Full Text] [Related]
4. [Listeria monocytogenes: a dangerous pathogen used as a vector for the new generation of vaccines].
Tkachuk MV; Iarovinskiĭ FO; Tonevitskiĭ AG
Vopr Med Khim; 2000; 46(3):256-64. PubMed ID: 11033885
[TBL] [Abstract][Full Text] [Related]
5. Listeria monocytogenes: a potent vaccine vector for neoplastic and infectious disease.
Weiskirch LM; Paterson Y
Immunol Rev; 1997 Aug; 158():159-69. PubMed ID: 9314084
[TBL] [Abstract][Full Text] [Related]
6. In vivo bactofection: listeria can function as a DNA-cancer vaccine.
Souders NC; Verch T; Paterson Y
DNA Cell Biol; 2006 Mar; 25(3):142-51. PubMed ID: 16569193
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of an attenuated Listeria monocytogenes as a vaccine vector to control Helicobacter pylori infection.
Wang S; Ma J; Ji Q; Liu Q
Immunol Lett; 2021 Oct; 238():68-74. PubMed ID: 34363896
[TBL] [Abstract][Full Text] [Related]
8. The TLR7 agonist imiquimod enhances the anti-melanoma effects of a recombinant Listeria monocytogenes vaccine.
Craft N; Bruhn KW; Nguyen BD; Prins R; Lin JW; Liau LM; Miller JF
J Immunol; 2005 Aug; 175(3):1983-90. PubMed ID: 16034143
[TBL] [Abstract][Full Text] [Related]
9. Impact of preexisting vector-specific immunity on vaccine potency: characterization of listeria monocytogenes-specific humoral and cellular immunity in humans and modeling studies using recombinant vaccines in mice.
Leong ML; Hampl J; Liu W; Mathur S; Bahjat KS; Luckett W; Dubensky TW; Brockstedt DG
Infect Immun; 2009 Sep; 77(9):3958-68. PubMed ID: 19528221
[TBL] [Abstract][Full Text] [Related]
10. Cancer immunotherapy using recombinant Listeria monocytogenes: transition from bench to clinic.
Singh R; Wallecha A
Hum Vaccin; 2011 May; 7(5):497-505. PubMed ID: 21422819
[TBL] [Abstract][Full Text] [Related]
11. Live-attenuated Listeria-based immunotherapy.
Rothman J; Paterson Y
Expert Rev Vaccines; 2013 May; 12(5):493-504. PubMed ID: 23659298
[TBL] [Abstract][Full Text] [Related]
12. Advances in the development of bacterial vector technology.
Kochi SK; Killeen KP; Ryan US
Expert Rev Vaccines; 2003 Feb; 2(1):31-43. PubMed ID: 12901595
[TBL] [Abstract][Full Text] [Related]
13. Listeria monocytogenes-based antibiotic resistance gene-free antigen delivery system applicable to other bacterial vectors and DNA vaccines.
Verch T; Pan ZK; Paterson Y
Infect Immun; 2004 Nov; 72(11):6418-25. PubMed ID: 15501772
[TBL] [Abstract][Full Text] [Related]
14. A novel human Her-2/neu chimeric molecule expressed by Listeria monocytogenes can elicit potent HLA-A2 restricted CD8-positive T cell responses and impact the growth and spread of Her-2/neu-positive breast tumors.
Seavey MM; Pan ZK; Maciag PC; Wallecha A; Rivera S; Paterson Y; Shahabi V
Clin Cancer Res; 2009 Feb; 15(3):924-32. PubMed ID: 19188163
[TBL] [Abstract][Full Text] [Related]
15. Listeria-based vaccines for cancer treatment.
Paterson Y; Maciag PC
Curr Opin Mol Ther; 2005 Oct; 7(5):454-60. PubMed ID: 16248280
[TBL] [Abstract][Full Text] [Related]
16. Multiple effector mechanisms induced by recombinant Listeria monocytogenes anticancer immunotherapeutics.
Wallecha A; Carroll KD; Maciag PC; Rivera S; Shahabi V; Paterson Y
Adv Appl Microbiol; 2009; 66():1-27. PubMed ID: 19203646
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Salmonella live vaccines with chromosomal expression cassettes for translocated fusion proteins.
Husseiny MI; Hensel M
Vaccine; 2009 Jun; 27(28):3780-7. PubMed ID: 19464562
[TBL] [Abstract][Full Text] [Related]
18. Listeria monocytogenes as an alternative vaccine vector for HIV.
Mata M; Paterson Y
Arch Immunol Ther Exp (Warsz); 2000; 48(3):151-62. PubMed ID: 10912619
[TBL] [Abstract][Full Text] [Related]
19. Clinical development of Listeria monocytogenes-based immunotherapies.
Le DT; Dubenksy TW; Brockstedt DG
Semin Oncol; 2012 Jun; 39(3):311-22. PubMed ID: 22595054
[TBL] [Abstract][Full Text] [Related]
20. The defined attenuated Listeria monocytogenes delta mp12 mutant is an effective oral vaccine carrier to trigger a long-lasting immune response against a mouse fibrosarcoma.
Paglia P; Arioli I; Frahm N; Chakraborty T; Colombo MP; Guzmàn CA
Eur J Immunol; 1997 Jun; 27(6):1570-5. PubMed ID: 9209512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
